Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance

被引：16
作者：
Zhang, Haozhe [1 ]
Zhou, Yi [1 ]
Xing, Zengzhen [1 ]
Sah, Rajiv Kumar [1 ]
Hu, Junqi [1 ]
Hu, Hailiang [1 ,2 ]
机构：
[1] So Univ Sci & Technol, Sch Med, Dept Biochem, Shenzhen 518055, Peoples R China
[2] Southern Univ Sci & Technol, Key Univ Lab Metab & Hlth Guangdong, Shenzhen 518055, Peoples R China
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2022年 / 23卷 / 21期
基金：
中国国家自然科学基金;
关键词：
androgen metabolism; androgen receptor; anti-androgen therapy; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; UDP-GLUCURONOSYLTRANSFERASES; INDEPENDENT GROWTH; CYP17A1; INHIBITION; BACKDOOR PATHWAY; RECEPTOR; CASTRATION; TESTOSTERONE; ABIRATERONE; EXPRESSION;
D O I：
10.3390/ijms232113521
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
All aspects of prostate cancer evolution are closely related to androgen levels and the status of the androgen receptor (AR). Almost all treatments target androgen metabolism pathways and AR, from castration-sensitive prostate cancer (CSPC) to castration-resistant prostate cancer (CRPC). Alterations in androgen metabolism and its response are one of the main reasons for prostate cancer drug resistance. In this review, we will introduce androgen metabolism, including how the androgen was synthesized, consumed, and responded to in healthy people and prostate cancer patients, and discuss how these alterations in androgen metabolism contribute to the resistance to anti-androgen therapy.
引用
收藏
页数：15
相关论文
共 117 条
  • [1] Agoulnik IU, 2008, ADV EXP MED BIOL, V617, P245, DOI 10.1007/978-0-387-69080-3_23
  • [2] HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer
    Almassi, Nima
    Reichard, Chad
    Li, Jianbo
    Russell, Carly
    Perry, Jaselle
    Ryan, Charles J.
    Friedlander, Terence
    Sharifi, Nima
    [J]. JAMA ONCOLOGY, 2018, 4 (04) : 554 - 557
  • [3] Changes of diurnal rhythm and levels of total and free testosterone secretion from pre to late puberty in boys: testis size of 3 ml is a transition stage to puberty
    Ankarberg-Lindgren, C
    Norjavaara, E
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 151 (06) : 747 - 757
  • [4] GUT MICROBIOTA DRIVE ANDROGEN RESISTANCE IN PROSTATE CANCER
    不详
    [J]. CANCER DISCOVERY, 2021, 11 (12) : 2959 - 2959
  • [5] AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
    Antonarakis, Emmanuel S.
    Lu, Changxue
    Wang, Hao
    Luber, Brandon
    Nakazawa, Mary
    Roeser, Jeffrey C.
    Chen, Yan
    Mohammad, Tabrez A.
    Chen, Yidong
    Fedor, Helen L.
    Lotan, Tamara L.
    Zheng, Qizhi
    De Marzo, Angelo M.
    Isaacs, John T.
    Isaacs, William B.
    Nadal, Rosa
    Paller, Channing J.
    Denmeade, Samuel R.
    Carducci, Michael A.
    Eisenberger, Mario A.
    Luo, Jun
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) : 1028 - 1038
  • [6] Clinical and Biochemical Consequences of CYP17A1 Inhibition with Abiraterone Given with and without Exogenous Glucocorticoids in Castrate Men with Advanced Prostate Cancer
    Attard, Gerhardt
    Reid, Alison H. M.
    Auchus, Richard J.
    Hughes, Beverly A.
    Cassidy, Amy Mulick
    Thompson, Emilda
    Oommen, Nikhil Babu
    Folkerd, Elizabeth
    Dowsett, Mitch
    Arlt, Wiebke
    de Bono, Johann S.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (02) : 507 - 516
  • [7] The backdoor pathway to dihydrotestosterone
    Auchus, RJ
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2004, 15 (09) : 432 - 438
  • [8] The Impact of Germline Genetic Variations in Hydroxysteroid (17-Beta) Dehydrogenases on Prostate Cancer Outcomes After Prostatectomy
    Audet-Walsh, Etienne
    Bellemare, Judith
    Lacombe, Louis
    Fradet, Yves
    Fradet, Vincent
    Douville, Pierre
    Guillemette, Chantal
    Levesque, Eric
    [J]. EUROPEAN UROLOGY, 2012, 62 (01) : 88 - 96
  • [9] Health Care Utilization and Costs of Patients With Prostate Cancer in China Based on National Health Insurance Database From 2015 to 2017
    Bai, Lin
    Wushouer, Haishaerjiang
    Huang, Cong
    Luo, Zhenhuan
    Guan, Xiaodong
    Shi, Luwen
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [10] Inactivation of androgens by UDP-glucuronosyltransferases in the human prostate
    Barbier, Olivier
    Belanger, Alain
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 22 (02) : 259 - 270
12345678910